Patents
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
06/2006
06/15/2006US20060128941 Pokeweed antiviral protein polypeptides with antiviral activity
06/15/2006US20060127899 Active carbohydrate containing protecting reagents for chemical modifications, their production and use
06/15/2006CA2590180A1 Binding partners of antibodies specific for dendritic cell antigens
06/13/2006US7060675 Administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes
06/08/2006WO2006004620A3 Enterotoxin gene cluster (egc) superantigens to treat malignant disease
06/08/2006US20060122368 Antigen delivery platform
06/07/2006EP1534718A4 Chemical synthesis of reagents for peptide coupling
06/06/2006US7056883 Therapeutic agent for soft tissue sarcoma
05/2006
05/31/2006EP1661907A1 A cardio myopeptidin, the production and the use thereof
05/31/2006EP1604032A4 Method for detecting prognosis of cancer
05/25/2006US20060111551 Peptide having HTLV-1-specific CTL-inducing activity
05/24/2006EP1658036A2 Estrogen receptor modulators and uses thereof
05/24/2006CN1777439A Somatostatin vectors
05/24/2006CN1775785A Methamidophos half-antigen, artificial antigen and its preparing method
05/23/2006US7049399 Making glatiramer acetate; polymerization of the N-carboxyanhydrides of L-alanine, tyrosine, gamma -benzyl glutamate and N epsilon-benzyloxycarbonyl lysine to make a protected copolymer, and deprotecting, separation and purification, in various solvents
05/23/2006US7049285 Spacers provide regions of hydrophobicity and positive charge and enhance their interaction with cell membrane to increase the cell trafficking, endosomal disruption, the circulation half-life in blood, and stability
05/23/2006US7049138 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/18/2006US20060104992 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating HIV
05/17/2006EP0973391B1 Endoderm, cardiac and neural inducing factors
05/16/2006US7045299 Digestive diseases; amino acid sequence 20 or 21; specific to orphan receptor protein ZAQ
05/10/2006EP1653991A2 Conjugates of a polymer and a protein linked by an oxime linking group
05/10/2006EP1653986A2 Treatment of cancers expressing p95 erbb2
05/10/2006EP1035860B1 Non-toxic immune stimulating enterotoxin compositions
05/10/2006CN1771052A Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
05/10/2006CN1771049A Somatostatin-dopamine chimeric analogs
05/04/2006WO2006045603A1 S-alkyl-sulphenyl protection groups in solid-phase synthesis
05/04/2006WO2006023029A3 The cysteine-rich region of respiratory syncytial virus and methods of use therefor
05/04/2006WO2005048944A3 Activatable photodynamic therapy agents
05/04/2006US20060094658 Method and compositions for the treatment of gastrointestinal disorders
05/04/2006CA2584906A1 S-alkyl-sulphenyl protection groups in solid-phase synthesis
05/03/2006EP1242060B1 Treatment of metastatic disease
05/03/2006CN1254483C Fast peptide-synthesizing process in solution
05/02/2006US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives
05/02/2006US7037691 A N-(3-(1-alkylimidazol-5-yl)-2-(protected amino)propionic acid)-terminated mono-, oligo- or polypeptide as catalysts for the regio-/enantioselective synthesis of cyclitol phosphates, particularly D-myo-inositol monophosphate libraries
04/2006
04/27/2006WO2006042374A1 Method for separating keratinous proteins from materials
04/27/2006CA2585342A1 Method for separating keratinous proteins from materials
04/25/2006US7034111 17867, a novel human aminopeptidase
04/25/2006US7034109 Intracellular delivery of biological effectors
04/20/2006WO2004091493A3 Improved heat shock protein-based vaccines and immunotherapies
04/19/2006EP1646646A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof.
04/19/2006CN1761482A Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
04/18/2006US7030227 Cell regulatory genes, encoded products, and uses related thereto
04/18/2006US7030210 Use of ligand binding domain as a diagnostic tool in detection of preferential biopolymers in sample
04/18/2006US7030084 Drug-oligomer conjugates with polyethylene glycol components
04/13/2006US20060078572 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever
04/12/2006EP1644729A2 Anti-cd74 immunoconjugates and methods
04/12/2006EP1644402A1 Arginine/lysine-enriched peptides
04/12/2006EP1644021A2 Methods and compositions for the treatment of gastrointestinal disorders
04/12/2006EP1005356B1 Novel antibacterial agents
04/12/2006CN1757724A Use of multiple recombination sites with unique specificity in recombinational cloning
04/12/2006CN1250567C Method of purifying calcium ion-binding protein
04/05/2006EP0946188B1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
04/05/2006CN1248732C Embonate medicine composition containing bombesin-like product
04/04/2006US7022328 Therapeutic and diagnostic compositions
03/2006
03/30/2006WO2004089297A3 Compounds and methods for treatment of thrombosis
03/23/2006US20060063918 Process for rapid solution synthesis of peptides
03/23/2006US20060063704 Somatostatin-dopamine chimeric analogs
03/22/2006EP1635879A2 Lectin conjugates
03/22/2006EP1635692A2 Monitoring immunologic, hematologic and inflammatory diseases
03/16/2006CA2577731A1 Peptide-based body surface reagents for personal care
03/14/2006US7012128 Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays
03/09/2006US20060052312 Paclitaxel hybrid derivatives
03/08/2006EP1631581A2 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
03/08/2006EP1631309A2 Protein kinase c peptides for use in withdrawal
03/01/2006EP1630170A1 A method of generating a crystal of a molecule-of-interest and a kit therefor
03/01/2006EP1105409B1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
03/01/2006CN1243760C Method for separation and purification of lecithin and cephalin
02/2006
02/23/2006CA2577995A1 Peptide inhibitors of c-jun dimerization and uses thereof
02/21/2006US7001982 Non-natural C-linked carbo-β-peptides with robust secondary structures
02/21/2006CA2091181C Cloning of chicken anaemia dna
02/16/2006US20060036070 Immunoglobulin a inducing protein and uses therefor
02/16/2006US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
02/15/2006EP1624884A2 Somatostatin vectors
02/09/2006CA2576037A1 Method of producing glycoprotein composition
02/08/2006EP1623994A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
02/08/2006EP1622563A2 Improved heat shock protein-based vaccines and immunotherapies
02/08/2006EP1267904A4 Polypeptoid pulmonary surfactants
02/07/2006US6995236 Sphingomyelin detecting probe
02/02/2006WO2006011589A1 Method of preparing artificial gene population and artificial protein population by random polymerization of motif sequences of multiple types
02/02/2006US20060025578 Chemical synthesis of reagents for peptide coupling
02/01/2006EP0969854B1 Inhibition of signal transduction by the binding of non-phosphorylated compositions
02/01/2006CN1239711C Bitterless soybean polypeptide and its production method
01/2006
01/26/2006US20060019309 Self-assembling peptide surfaces for cell patterning and interactions
01/26/2006US20060018919 Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines
01/25/2006EP1617856A2 Somatostatin-dopamine chimeric analogs
01/25/2006EP1617804A2 Improved heat shock protein-based vaccines and immunotherapies
01/25/2006EP1474430B1 Bi-functionalised metallocenes use for marking biological molecules
01/19/2006WO2006006521A1 Composite of polysaccharide with protein and emulsifying agent and emulsion each containing the same
01/19/2006US20060014926 Human papillomavirus E6 and E7 polypeptides, mutant polypeptide retains 30% of the immunogenicity of an isolated polypeptide comprising human wild-type papillomavirus E6 and E7
01/19/2006US20060014672 Tumor specific oligosaccharide epitopes and use thereof
01/12/2006US20060008853 Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the same
01/11/2006EP1613642A2 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
01/05/2006US20060004184 Method and device for detecting feline immunodeficiency virus
01/05/2006US20060003386 Metallopeptide combinatorial libraries and applications
01/03/2006US6982149 Fiber array and methods for using and making same
12/2005
12/29/2005WO2004021861A3 Targeted release
12/29/2005US20050288260 Novel nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
12/22/2005WO2005121166A1 Novel immunointeractive molecules and uses thereof
12/22/2005WO2005077003A3 Pili from mycobacterium tuberculosis
12/21/2005EP1606232A1 Improved extraction process
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 48